Organ preservation by combined modality treatment in bladder cancer: The European perspective

Seminars in Radiation Oncology

Volumn 15, Issue 1, 2005, Pages 28-35

  Rödel, Claus ^a   Weiss, Christian ^a   Sauer, Rolf ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; PACLITAXEL; TAXANE DERIVATIVE; THIOTEPA;

ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BLADDER TUMOR; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; CYSTITIS; ENTERITIS; GASTROINTESTINAL TOXICITY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; ORGAN PRESERVATION; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; REVIEW; SALVAGE THERAPY; SEXUAL FUNCTION; SIDE EFFECT; TRANSURETHRAL RESECTION; TUMOR VOLUME; UROGENITAL TRACT TUMOR;

EID: 12344266516     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2004.07.010     Document Type: Article

References (50)

1. J. Dunst, C. Rödel, A. Zietman Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy Semin Surg Oncol 20 2001 24 32
2. W.U. Shipley, D.S. Kaufman, W.J. Tester Overview of bladder cancer trials in the radiation Therapy Oncology Group Cancer 97 suppl 8 2003 2115 2119
3. M. Housset, C. Moulard, Y. Chretien Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder a prospective study J Clin Oncol 11 1993 2150 2157
4. R. Sauer, J. Dunst, A. Altendorf-Hofmann Radiotherapy with and without cisplatin in bladder cancer Int J Radiat Oncol Biol Phys 19 1990 687 691
5. W.U. Shipley, G.R. Prout, A.B. Einstein Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery JAMA 258 1987 931 943
6. J. Dunst, R. Sauer, K.M. Schrott Organ-sparing treatment of advanced bladder cancer a 10-year experience Int J Radiat Oncol Biol Phys 30 1994 261 266
7. G. Fellin, U. Graffer, A. Bolner Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study Br J Urol 80 1997 44
8. R. Sauer, S. Birkenhake, R. Kühn Efficacy of radiochemotherapy with platin derivates compared to radiotherapy alone in organ-sparing treatment of bladder cancer Int J Radiat Biol Phys 40 1998 121 127
9. J. Cervek, T. Cufer, B. Zakotnik Invasive bladder cancer our experience with bladder sparing approach Int J Radiat Oncol Biol Phys 41 1998 273 278
10. A. Zapatero, C. Martin de Vidales, A. Marin Invasive bladder cancer a single-institution experience with bladder-sparing approach Int J Cancer (Radiat Oncol Invest) 90 2000 287 294
11. F. Arias, M.A. Domingues, E. Martinez Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program Int J Radiat Oncol Biol Phys 47 2000 373 378
12. C. Rödel, G.G. Grabenbauer, R. Kühn Combined-modality treatment and selective organ preservation in invasive bladder cancer Long-term results J Clin Oncol 20 2002 3061 3071
13. C.M. Coppin, M.K. Gospodarowicz, K. James Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation J Clin Oncol 14 1996 2901 2907
14. J. Bellmunt, V. Guillem, L. Paz-Area Phase I/II study of paclitaxel, cisplatin and gemcitabine in advanced transitional-cell carcinoma of the urothelium J Clin Oncol 18 2000 3247 3255
15. O. Caffo, G. Fellin, U. Graffer Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer Int J Radiat Oncol Biol Phys 57 2003 1310 1316
16. H. Varveris, D. Delakas, P. Anezinis Concurrent platinum and docetaxel and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma A preliminary report of tolerance and local control. Anticancer Res 17 1997 4771 4780
17. J. Dunst, C. Weigel, H. Heynemann Preliminary results of simultaneous radiochemotherapy with paclitaxel for urinary bladder cancer Strahlenther Onkol 175 1999 7 10
18. R.C. Nichols, M.G. Sweetser, S.K. Mahmood Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder a well tolerated combination Int J Cancer 90 2000 281 286
19. E. Cohen-Jonathan, R.J. Muschel, W. Gillies McKenna Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS Radiat Res 154 2000 125 132
20. J. Bellmunt, M. Hussain, C.P. Dinney Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family Crit Rev Oncol Hematol 46 2003 85 104
21. A.L. Zietman, J. Grocela, E. Zehr Selective bladder preservation using transurethral resection, chemotherapy, and radiation Management and consequences of Ta, T1, and TIS recurrences within the retained bladder Urology 58 2001 380 385
22. J.A. Freemann, D. Esrig, J.P. Stein Radical cystectomy for high risk superficial bladder cancer in the era of ortotopic urinary reconstruction Cancer 76 2001 833 839
23. Dutch South Eastern Bladder Cancer Study Group P.F. Mulders, W.J. Hoekstra, R.P. Heybrock Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients Eur J Cancer 30 2001 914 917
24. B. Van der Werf-Messing, W.J.C. Hop Carcinoma of the urinary bladder (T1N0M0) treated either by radium implant or transurethral resection ony Int J Radiat Oncol Biol Phys 7 2001 299 303
25. E.M. Van der Steen-Banasik, A.G. Visser, J.G. Reinders Saving bladders with brachytherapy implantation technique and results Int J Radiat Oncol Biol Phys 53 2002 622 629
26. C. Rödel, J. Dunst, G.G. Grabenbauer Radiotherapy is an effective treatment for high-risk T1-bladder cancer Strahlenther Onkol 177 2001 82 88
27. L. Henningsohn, H. Wijkström, P.W. Dickman Distressful symptoms after radical radiotherapy for urinary bladder Radiother Oncol 62 2002 215 225
28. A. Zietman, D. Sacco, U. Skowronski Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation results of a urodynamic and quality of life study on long-term survivors J Urol 170 2003 1772 1776
29. V. Chyle, A. Pollack, B. Czerniak Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer Int J Radiat Oncol Biol Phys 35 1996 281 287
30. L. Moonen, F. Ong, M. Gallee Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder Int J Radiat Oncol Biol Phys 49 2001 1305 1310
31. S. Harada, R. Sato, R. Nakamura The correlation between spontaneous and radiation-induced apoptosis in T3B bladder cancer (histological grade G3), and the precedence between the two kinds of apoptosis for predicting clinical prognosis Int J Radiat Oncol Biol Phys 48 2000 1059 1067
32. C. Rödel, G.G. Grabenbauer, F. Rödel Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma possible predictors for response to radiochemotherapy and successful bladder preservation Int J Radiat Oncol Biol Phys 46 2000 1213 1221
33. P.C. Lara, S. Perez, A. Rey Apoptosis in carcinoma of the bladder relation with radiation treatment results Int J Radiat Oncol Biol Phys 43 1999 1015 1019
34. S.A. Hussain, R. Ganesan, L. Hiller BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder Oncol Rep 10 2003 571 576
35. F. Ong, L.M. Moonen, M.P. Gallee Prognostic factors in transitional cell cancer of the bladder an emerging role for Bcl-2 and p53 Radiother Oncol 61 2001 169 175
36. A. Pollack, C.S. Wu, B. Czerniak Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer Clin Cancer Res 3 1997 1823 1829
37. G. Kong, K.Y. Shin, Y.H. Oh Bcl-2 and p53 expressions in invasive bladder cancers Acta Oncol 37 1998 715 720
38. C.S. Wu, A. Pollack, B. Czerniak Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy Urology 47 1996 305 310
39. R. Rotterud, A. Berner, R. Holm p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder BJU Int 88 2001 202 208
40. K.N. Qureshi, T.R. Griffiths, M.C. Robinson Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapy Int J Radiat Oncol Biol Phys 51 2001 1234 1240
41. I. Osen, S.D. Fossa, B. Majak Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy an immunohistochemical study Br J Urol 81 1998 862 869
42. S. Jahnson, B. Risberg, M.G. Karlsson p53 and Rb immunostaining in locally advanced bladder cancer relation to prognostic variables and predictive value for the local response to radical radiotherapy Eur Urol 28 1995 135 142
43. M. Agerbaek, J. Alsner, N. Marcussen Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer Br J Cancer 89 2003 298 304
44. K.Y. Shin, G. Kong, W.S. Kim Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers Br J Cancer 75 1997 1788 1792
45. P.C. Lara, A. Rey, C. Santana The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy Radiother Oncol 49 1998 163 167
46. E.B. Hug, S.M. Donnelly, W.U. Shipley Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy- radiotherapy J Urol 148 1992 47 51
47. B.J. Jenkins, J.E. Martin, S.I. Baithun Prediction of response to radiotherapy in invasive bladder cancer Br J Urol 65 1990 345 348
48. H. Wijkstrom, B. Nilsson, B. Tribukait DNA analysis in predicting survival of irradiated patients with transitional cell carcinoma of bladder Br J Urol 69 1992 49 55
49. H. Wijkstrom, B. Tribukait Deoxyribonucleic acid flow cytometry in predicting response to radical radiotherapy of bladder cancer J Urol 144 1990 646 650
50. J.P. Stein, G. Lieskovsky, R. Cote Radical cystectomy in the treatment of invasive bladder cancer long-term results in 1,054 patients J Clin Oncol 19 2001 666 675